drugset / Trial / NCT00304811
Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection
Phase 4
Completed
160 enrolled
Michael E. DeBakey VA Medical Center
Baylor College of Medicine · collab
RandomizedParallel-groupSingle-blind
Summary
The purpose of this study is to compare the outcome of treatment for bacteremic MRSA infection with vancomycin alone, vancomycin plus gentamicin, vancomycin plus rifampin, and vancomycin plus gentamicin and rifampin.
Timeline
- Start
- 2006-01
- Primary completion
- 2007-01
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gentamicin | Small molecule | — | — |
| Subject | Rifampin | Small molecule | — | — |
| Background | Vancomycin | Other / unclassified | — | — |